trending Market Intelligence /marketintelligence/en/news-insights/trending/HuaaskiDHwhME7JdhsXG7A2 content esgSubNav
In This List

Veritas Pharma CFO resigns; interim replacement named

Blog

Funding Social and Affordable Housing: A Credit Perspective

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals


Veritas Pharma CFO resigns; interim replacement named

David Alexander resigned as the CFO and a director of Veritas Pharma Inc.

The company appointed Peter McFadden to replace Alexander as CFO on an interim basis.

Veritas Pharma develops proprietary cannabis strains for chronic and acute pains, nausea and vomiting, and post-traumatic stress disorders.